Favourable response of serum prostate-specific antigen to conjugated oestrogen in castrate-resistant prostate cancer in Jamaica

Conjugated oestrogen is one of the more affordable secondary hormonal options available for castrate-resistant prostate cancer (CRPC) in Jamaica. The present study was conducted to examine the disease response in Jamaican men with CRPC treated with conjugated oestrogen. This study retrospectively re...

Descripción completa

Detalles Bibliográficos
Autores principales: Condappa, Andrew, Gossell-Williams, Maxine, Aiken, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2018
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931810/
https://www.ncbi.nlm.nih.gov/pubmed/29743949
http://dx.doi.org/10.3332/ecancer.2018.829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931810/
https://www.ncbi.nlm.nih.gov/pubmed/29743949
http://dx.doi.org/10.3332/ecancer.2018.829

Ejemplares similares